This brief highlights a development in psychopharmacology that directly relates to mood regulation and resilience, areas of ongoing clinical interest for mental health practitioners. The reported work describes psychedelic-like compounds that engage serotonin pathways linked to brain plasticity without eliciting full psychedelic effects in animal models, suggesting a potential path to novel depression treatments with fewer experiential risks. For therapists, the finding may inform future conversations about emerging pharmacotherapies and the mechanisms by which mood and plasticity are influenced.
Article Title: New psychedelic-like drugs could treat depression without making you trip
Link to Science Daily Mind-Brain News: https://nolinkpreview.com/www.sciencedaily.com/releases/2026/05/260512202325.htm
#mentalhealth #psychiatry #psychopharmacology #serotonin #brainplasticity #depressiontreatment #therapists #socialworkers #mentalhealthprofessionals #neuropharmacology



